Enzyre announces strategic partnership with Takeda
Enzyre announces strategic partnership with Takeda to accelerate development of pioneering diagnostic technology platform for hemophilia patients Enzyre’s diagnostic technology platform will enable patient testing and monitoring of congenital bleeding disorders in a home setting